Melatech ApS
Key figures
- Return on assets
- -24.6%
- Return on equity
- -51.5%
- Current ratio
- 295.7%
- Equity ratio
- 53.8%
Profit and loss
| Reporting period | |
|---|---|
Gross profit | 8,827,800 |
Operating profit | -2,214,521 |
Finance expenses | 108,537 |
Tax expense | 0 |
Profit/loss for the year | -2,491,195 |
Employees
| Reporting period | |
|---|---|
Avg. employees | 19 |
Personnel costs | 11,042,321 DKK |
Balance sheet
| Reporting period | |
|---|---|
Cash and cash equivalents | 3,941,172 |
Current assets | 8,797,636 |
Non-current assets | 189,675 |
Total assets | 8,987,311 |
Equity | 4,839,633 |
Liabilities | 4,147,678 |
Current liabilities | 2,975,303 |
Working capital
| Reporting period | |
|---|---|
Inventories | 1,441,670 |
Trade receivables | 3,014,669 |
Other current receivables | 41,274 |
Trade payables | 119,905 |
Capital and dividend
| Reporting period | |
|---|---|
Contributed capital | 914,427 |
Retained earnings | 3,925,206 |
Investments and assets
| Reporting period | |
|---|---|
Long-term investments and receivables | 189,675 |
Annual report highlights
Business and development
The Company's principal activities are to conduct a development, trade and service business within the health technology sector, as well as any business related hereto, at the Management's discretion.
Development in activities and financial and economic position
In 2025 Melatech continued building its platform for specialist support in primary care, augmented by hardware and administrative AI. Commercial revenue grew strongly, with the Danish businessremaining as the comapany’s profitable foundation. In Denmark the Company expanded to nearly 50% of the entire primary care sector, while advancing pilots and contracts in the United States and continuing early activity in Germany. As planned, the company recorded a net loss for the year, reflecting deliberate investment in platform expansion and new-market entry. Looking ahead, Melatech aims to further its activities through application expansion with a focus on Denmark and broad market expansion of our dermatological application.
Risks and material matters
Significant events after the end of the financial year
No events have occurred after the end of the financial year of material importance for the Company's financial position.
Commitments and security
Lease liabilities
The company has entered into lease commitments which, at the balance sheet date, amount to DKK 745 thousand within the non-cancellable period, expiring on 15 December 2027
5 | Charges and securities
As security for a promissory note of DKK 990 thousand, the Company has granted a floating charge of a nominal amount of DKK 4,345 thousand. The floating charge comprises the following assets, whose carrying amounts at the balance sheet date are as follows:…
5 | Charges and securities
As security for a promissory note of DKK 990 thousand, the Company has granted a floating charge of a nominal amount of DKK 4,345 thousand. The floating charge comprises the following assets, whose carrying amounts at the balance sheet date are as follows:…
Create a free account to see up to 9 years of financial history
Create free account